Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Measurement of pain during first trimester medical abortion: an exploratory qualitative study.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026

Same author

Advantages and disadvantages of peri-abortion ultrasonography.

Reproduction & fertility·2026

Same author

Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service.

BMJ sexual & reproductive health·2026

Same author

Outcomes of medical abortion with an intrauterine device <i>in situ:</i> a retrospective review.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2025

Same author

Safety and efficacy of early medical abortion at home between 10+0 and 11+6 weeks' gestation: a retrospective review.

BMJ sexual & reproductive health·2025

Same author

The CPLAN study: Clotting Parameters after medicaL AbortioN.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2025

Search research articles

Related Experiment Video

Updated: May 25, 2025

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

Early medical abortion.

Sharon T Cameron¹

¹Centre for Reproductive Health, Institute for Repair and Regeneration, University of Edinburgh, Edinburgh, UK; Chalmers Centre for Sexual and Reproductive Healthcare, NHS Lothian, Edinburgh, UK.

Best Practice & Research. Clinical Obstetrics & Gynaecology

|February 27, 2025

Summary

This summary is machine-generated.

Early medical abortion using mifepristone and misoprostol is becoming safer and more accessible. Women can self-manage this procedure at home, with telemedicine further expanding access to safe abortion services.

Keywords:

Contraception Medical abortion Mifepristone Misoprostol Telemedicine

More Related Videos

Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5

Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5

Published on: February 14, 2022

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

Published on: February 4, 2015

Related Experiment Videos

Last Updated: May 25, 2025

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5

Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5

Published on: February 14, 2022

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

Published on: February 4, 2015

Area of Science:

Reproductive Health
Pharmacology

Background:

Early medical abortion (EMA) has evolved significantly over 35 years.
Current drug regimens and procedures for EMA have been simplified.

Purpose of the Study:

To review the evolving landscape of early medical abortion.
To highlight the safety and efficacy of self-managed EMA and telemedicine.

Main Methods:

Evidence review of self-administration of mifepristone and misoprostol.
Analysis of telemedicine's role in EMA delivery.
Assessment of current EMA practices and future research needs.

Main Results:

Women can safely self-administer EMA medications at home.
Telemedicine for EMA shows comparable outcomes to traditional methods and is well-accepted.
Self-performed pregnancy tests are effective for confirming EMA success.

Conclusions:

EMA is a safe and accessible option, with increasing evidence supporting self-management.
Telemedicine enhances EMA accessibility, particularly for remote populations.
Further research is needed to optimize pain management and expand access in early gestations and remote settings.